157 related articles for article (PubMed ID: 35211354)
1. Alternative splicing and alternative polyadenylation define tumor immune microenvironment and pharmacogenomic landscape in clear cell renal carcinoma.
Zhong W; Wu Y; Zhu M; Zhong H; Huang C; Lin Y; Huang J
Mol Ther Nucleic Acids; 2022 Mar; 27():927-946. PubMed ID: 35211354
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of alternative polyadenylation regulators of CTLA4 and immune infiltration in clear cell renal cell carcinoma.
Zhou M; Long W; Xiong M; Zhang F; Chen L; Chen J; Pang Z; Hou T; Li W
Transl Androl Urol; 2023 Apr; 12(4):533-548. PubMed ID: 37181233
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of immune-related gene subtype and immune index for immunotherapy in clear cell renal cell carcinoma.
Bai D; Chen S; Feng H; Yin A; Lu J; Ma Y; Sugiyama H
Pathol Res Pract; 2021 Sep; 225():153557. PubMed ID: 34329838
[TBL] [Abstract][Full Text] [Related]
4. The Transcriptional Landscape of Immune-Response 3'-UTR Alternative Polyadenylation in Melanoma.
Yang X; Wu Y; Chen X; Qiu J; Huang C
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474285
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Immune-Related Alternative Polyadenylation Events in Cancer Immunotherapy.
Wang G; Xie Z; Su J; Chen M; Du Y; Gao Q; Zhang G; Zhang H; Chen X; Liu H; Han L; Ye Y
Cancer Res; 2022 Oct; 82(19):3474-3485. PubMed ID: 35930727
[TBL] [Abstract][Full Text] [Related]
7. Alternative Polyadenylation Regulatory Factors Signature for Survival Prediction in Kidney Renal Cell Carcinoma.
Wang X; Lin Y; Li Z; Li Y; Chen M
Cancer Inform; 2024; 23():11769351231180789. PubMed ID: 38617569
[TBL] [Abstract][Full Text] [Related]
8. Aging-based molecular classification and score system in ccRCC uncovers distinct prognosis, tumor immunogenicity, and treatment sensitivity.
Zhu M; Huang C; Wu X; Gu Y; Hu X; Ma D; Zhong W
Front Immunol; 2022; 13():877076. PubMed ID: 36032073
[TBL] [Abstract][Full Text] [Related]
9. Novel insights into clear cell renal cell carcinoma prognosis by comprehensive characterization of aberrant alternative splicing signature: a study based on large-scale sequencing data.
Zhang D; Zhang W; Sun R; Huang Z
Bioengineered; 2021 Dec; 12(1):1091-1110. PubMed ID: 33783315
[TBL] [Abstract][Full Text] [Related]
10. m
Zhong J; Liu Z; Cai C; Duan X; Deng T; Zeng G
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33574053
[TBL] [Abstract][Full Text] [Related]
11. PABPN1 promotes clear cell renal cell carcinoma progression by suppressing the alternative polyadenylation of SGPL1 and CREG1.
Xiong M; Liu C; Li W; Jiang H; Long W; Zhou M; Yang C; Kazobinka G; Sun Y; Zhao J; Hou T
Carcinogenesis; 2023 Oct; 44(7):576-586. PubMed ID: 37452741
[TBL] [Abstract][Full Text] [Related]
12. Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma.
Xu W; Zhu W; Tian X; Liu W; Wu Y; Anwaier A; Su J; Wei S; Qu Y; Zhang H; Ye D
Front Cell Dev Biol; 2021; 9():772436. PubMed ID: 34957104
[TBL] [Abstract][Full Text] [Related]
13. Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.
Kim N; Chung W; Eum HH; Lee HO; Park WY
PLoS One; 2019; 14(5):e0217196. PubMed ID: 31100099
[TBL] [Abstract][Full Text] [Related]
14. Cleavage and Polyadenylation Specific Factor 1 Promotes Tumor Progression
Chen SL; Zhu ZX; Yang X; Liu LL; He YF; Yang MM; Guan XY; Wang X; Yun JP
Front Cell Dev Biol; 2021; 9():616835. PubMed ID: 33748106
[TBL] [Abstract][Full Text] [Related]
15. Alternative polyadenylation is associated with lower expression of PABPN1 and poor prognosis in non-small cell lung cancer.
Ichinose J; Watanabe K; Sano A; Nagase T; Nakajima J; Fukayama M; Yatomi Y; Ohishi N; Takai D
Cancer Sci; 2014 Sep; 105(9):1135-41. PubMed ID: 24975429
[TBL] [Abstract][Full Text] [Related]
16. Landscape of Immune Microenvironment Under Immune Cell Infiltration Pattern in Breast Cancer.
Xu Q; Chen S; Hu Y; Huang W
Front Immunol; 2021; 12():711433. PubMed ID: 34512634
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin Modification Patterns of Clear Cell Renal Cell Carcinoma and the Ubiquitin Score to Aid Immunotherapy and Targeted Therapy.
Zhou P; Lu Y; Xun Y; Xu J; Liu C; Xia Q; Lu J; Wang S; Hu J
Front Cell Dev Biol; 2021; 9():659294. PubMed ID: 34055790
[TBL] [Abstract][Full Text] [Related]
18. Genome-Wide Profiling Reveals Alternative Polyadenylation of Innate Immune-Related mRNA in Patients With COVID-19.
An S; Li Y; Lin Y; Chu J; Su J; Chen Q; Wang H; Pan P; Zheng R; Li J; Jiang J; Ye L; Liang H
Front Immunol; 2021; 12():756288. PubMed ID: 34777369
[TBL] [Abstract][Full Text] [Related]
19. CAFuncAPA: a knowledgebase for systematic functional annotations of APA events in human cancers.
Huang K; Wu S; Yang X; Wang T; Liu X; Zhou X; Huang L
NAR Cancer; 2023 Mar; 5(1):zcad004. PubMed ID: 36694725
[TBL] [Abstract][Full Text] [Related]
20. Integrative Analysis of Immune-Related Genes in the Tumor Microenvironment of Renal Clear Cell Carcinoma and Renal Papillary Cell Carcinoma.
Zheng B; Xie F; Cheng F; Wang J; Yao Z; He W; Niu Z
Front Mol Biosci; 2021; 8():760031. PubMed ID: 34888353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
